Your browser doesn't support javascript.
loading
Potential usage of anterior nasal sampling in clinical practice with three rapid antigen tests for SARS-CoV-2.
Nomoto, Hidetoshi; Yamamoto, Kei; Isaka, Erina; Miyazato, Yusuke; Suzuki, Tetsuya; Maruki, Taketomo; Yamada, Gen; Kamegai, Kohei; Akiyama, Yutaro; Ide, Satoshi; Kurokawa, Masami; Moriya, Ataru; Mezaki, Kazuhisa; Yagi, Shintaro; Nojima, Hisashi; Yamakawa, Kentaro; Ohmagari, Norio.
Affiliation
  • Nomoto H; Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan; Emerging and Reemerging Infectious Diseases, National Center for Global Health and Medicine, Graduate School of Medicine, Tohoku University, 2-1 Seiryo-cho, Aoba
  • Yamamoto K; Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan. Electronic address: kyamamoto@hosp.ncgm.go.jp.
  • Isaka E; Clinical Laboratory, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.
  • Miyazato Y; Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.
  • Suzuki T; Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan; Emerging and Reemerging Infectious Diseases, National Center for Global Health and Medicine, Graduate School of Medicine, Tohoku University, 2-1 Seiryo-cho, Aoba
  • Maruki T; Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.
  • Yamada G; Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.
  • Kamegai K; Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.
  • Akiyama Y; Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.
  • Ide S; Emerging and Reemerging Infectious Diseases, National Center for Global Health and Medicine, Graduate School of Medicine, Tohoku University, 2-1 Seiryo-cho, Aoba-ku, Sendai city, Miyagi, 980-8575, Japan; Department of General Internal Medicine, National Center for Global Health and Medicine, 1-21-1
  • Kurokawa M; Clinical Laboratory, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.
  • Moriya A; Clinical Laboratory, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.
  • Mezaki K; Clinical Laboratory, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.
  • Yagi S; Research and Development Division, Fujirebio Inc, 935 Ishikawa-cho, Hachioji, Tokyo, 192-0032, Japan.
  • Nojima H; Research and Development Division, Fujirebio Inc, 935 Ishikawa-cho, Hachioji, Tokyo, 192-0032, Japan.
  • Yamakawa K; Research and Development Division, Fujirebio Inc, 935 Ishikawa-cho, Hachioji, Tokyo, 192-0032, Japan.
  • Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan; Emerging and Reemerging Infectious Diseases, National Center for Global Health and Medicine, Graduate School of Medicine, Tohoku University, 2-1 Seiryo-cho, Aoba
J Infect Chemother ; 29(1): 15-19, 2023 Jan.
Article in En | MEDLINE | ID: mdl-36089257
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: En Journal: J Infect Chemother Journal subject: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: En Journal: J Infect Chemother Journal subject: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2023 Document type: Article